drugset
drugset / Trial / NCT01706796

A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State

NCT01706796 ↗

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to estimate the relative bioavailability and food effect of PF-06273340 tablets.

Timeline

Start
2012-11
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06273340 Small molecule — Oral

Indications

No indication recorded.